Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions

8月 04, 2022

特許

This content is available on the Kluwer Patent Blog

‍

Our partner Felipe Mesquita and attorney at law Carolina Mendes had their article “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” published this Thursday (August 4), by the "Kluwer Patent Blog" website. It addresses recent decisions in litigation involving pharma patents that honor the protection of industrial property rights despite the public health challenges faced in Brazil. Full article at: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/

Felipe Mesquita sócio e Carolina Mendes, advogada, tiveram seu artigo “Biotechnology/pharma patent litigation in Brazil: an update on preliminary injunctions” publicado hoje (4/8), no site "Kluwer Patent Blog". O artigo aborda recentes decisões em litígios envolvendo patentes farmacêuticas que prestigiam a proteção aos direitos de propriedade industrial apesar dos desafios de saúde pública enfrentados no Brasil. Leia o texto na íntegra: http://patentblog.kluweriplaw.com/2022/08/04/biotechnology-pharma-patent-litigation-in-brazil-an-update-on-preliminary-injunctions/

‍